Global Hydroxychloroquine Market was estimated to be US$ 41.3 Mn in 2018 and is expected to reach US$ 100.4 Mn by 2030 growing at a CAGR of 10.4% over the forecast period. Rise in outbreak of global pandemic coronavirus or COVID-19 alerted governments and health authorities across various countries to develop preventive and curative medicines for this infectious disease. COVID-19 affect the immune system of lungs of infected persons. People with weak immune systems and having previous autoimmune disorders have a high probability of contacting the virus compared to other individuals. Presently government organizations, private organizations and healthcare service providers across the world is in research & development for a vaccine for COVID-19. Before a vaccine is commercially available, there is a growing for development of medicines that can suppress the effects of COVID-19 in human body. Presently a notable drug used in suppressing the effects of COVID-19 in human body is hydroxychloroquine (also known by the brand name ‘Plaquenil’). Generally hydroxychloroquine sulfate primarily used for autoimmune diseases including rheumatoid arthritis, lupus, malaria and other diseases. Hydroxychloroquine sulfate is a major drug used for curing malaria. The drug is currently available as a generic drug in the form of tablets majorly in the 200 mg formulation.

Access the Full Report @ https://www.absolutemarketsinsights.com/reports/Hydroxychloroquine-Market-2019-2027-546

The detailed research study provides qualitative and quantitative analysis of hydroxychloroquine market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Key Findings of the Report:

  • In terms of the application for hydroxychloroquine, coronavirus (COVID-19) is expected to be the major contributor of revenue to the market over the near future. The growth in cases across various countries is expected to drive the demand for the drug.
  • The distribution of hydroxychloroquine is observed to made more through the offline medium. The primary reasons for the same are the easier availability of the drug and the growing network of pharmacies and medical centers across the world.
  • As far as geography is concerned, North America accounted for the maximum share in the global hydroxychloroquine market in 2018. This can be attributed to the higher instances of autoimmune diseases amongst the population and growing manufacturer presence in the region.
  • Some of the players operating in the hydroxychloroquine market are Amneal Pharmaceuticals LLC., Dr. Reddy’s Laboratories, Inc, Ipca Laboratories Ltd., Laurus Labs Limited, Mylan N.V., NorthStar Rx LLC, Novartis AG, Prasco Laboratories, Sanofi, Teva Pharmaceutical Industries Ltd., and Zydus Cadila amongst others.

Hydroxychloroquine Market:

By Application

  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Malaria
  • Coronavirus (COVID-19)
  • Others

By Product Type

  • 200 mg
  • 300 mg
  • 400 mg
  • Others

By Distribution Channel

  • Online
  • Offline
  • Retail Pharmacies
  • Hospitals/Clinics
  • Others

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com